Organism: Homo sapiens
Gene: 39741_at
Selected probe(set): 201007_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 39741_at (201007_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-2.1147547
Number of Samples:3 / 3

Experimental	oncolytic herpes simplex virus study 2
	Human malignant peripheral nerve sheath tumor (S462) cells infected with G207, an ICP34.5-deleted oncolytic herpes simplex virus (oHSV) for 6 hours.
Control	mock infected peripheral nerve sheath tumor (S462) cell sample
	Human malignant peripheral nerve sheath tumor (S462) cells mock infected for 6 hours.

Relative Expression (log2-ratio):2.0106573
Number of Samples:3 / 3

Experimental	myotonic dystrophy study 4 (deltoid muscle; DM2)
	Deltoid muscle biopsies obtained from patients with myotonic dystrophy type 2 (DM2).
Control	normal skeletal muscle tisuue (fetal)
	Commercially purchased normal fetal skeletal muscle tissue samples.

Relative Expression (log2-ratio):1.8561869
Number of Samples:3 / 3

Experimental	myotonic dystrophy study 4 (biceps brachii; DM2)
	Biceps brachii biopsies obtained from patients with myotonic dystrophy type 2 (DM2).
Control	normal skeletal muscle tisuue (fetal)
	Commercially purchased normal fetal skeletal muscle tissue samples.

Relative Expression (log2-ratio):1.8168383
Number of Samples:8 / 3

Experimental	myotonic dystrophy study 4 (skeletal muscle; DM2)
	Unspecified skeletal muscle biopsies obtained from patients with myotonic dystrophy type 2 (DM2).
Control	normal skeletal muscle tisuue (fetal)
	Commercially purchased normal fetal skeletal muscle tissue samples.

Relative Expression (log2-ratio):1.7227335
Number of Samples:9 / 3

Experimental	myotonic dystrophy study 4 (biceps brachii; DM-like)
	Biceps brachii biopsies obtained from patients with myotonic-like dystrophy (DMx; DM-like; no DMPK or ZNF9 expansion).
Control	normal skeletal muscle tisuue (fetal)
	Commercially purchased normal fetal skeletal muscle tissue samples.

Relative Expression (log2-ratio):-1.6841116
Number of Samples:4 / 6

Experimental	F. tularensis study 1 (tularensis Schu S4)
	Peripheral blood monocytes infected with the Schu S4 isolate of Francisella tularensis (100 MOI) for 24 hours.
Control	uninfected peripheral blood monocyte sample
	Peripheral blood monocytes uninfected.

Relative Expression (log2-ratio):1.673255
Number of Samples:3 / 3

Experimental	myotonic dystrophy study 4 (deltoid muscle; DM-like)
	Deltoid muscle biopsies obtained from patients with myotonic-like dystrophy (DMx; DM-like; no DMPK or ZNF9 expansion).
Control	normal skeletal muscle tisuue (fetal)
	Commercially purchased normal fetal skeletal muscle tissue samples.

Relative Expression (log2-ratio):1.654582
Number of Samples:2 / 3

Experimental	myotonic dystrophy study 4 (deltoid muscle; DM1)
	Deltoid muscle biopsies obtained from patients with myotonic dystrophy type 1 (DM1).
Control	normal skeletal muscle tisuue (fetal)
	Commercially purchased normal fetal skeletal muscle tissue samples.

Relative Expression (log2-ratio):-1.648839
Number of Samples:12 / 20

Experimental	endometriosis study 6 (minimal/mild endo.; pro. MCP)
	Endometrial tissue samples from women with minimal or mild endometriosis and pelvic pain and/or infertility collected in the proliferative menstrual cycle phase (MCP). Endometriosis was diagnosed based on the revised American Fertility Society classification system. The MCP was determined by endometrial histology, confirmed by estradiol and progesterone serum levels and corroborated by 2 independent bioinformatics methods: clustering in unsupervised whole-transcriptome principal component analysis and cycle phase assignment classifier analysis. Patients with hormonal treatment within previous 3 months and presence of malignancy or major systemic disease were excluded.
Control	normal endometrium tissue (pro. MCP)
	Normal endometrial tissue samples from women collected in the proliferative menstrual cycle phase (MCP). The MCP was determined by endometrial histology, confirmed by estradiol and progesterone serum levels and corroborated by 2 independent bioinformatics methods: clustering in unsupervised whole-transcriptome principal component analysis and cycle phase assignment classifier analysis.

Relative Expression (log2-ratio):-1.6465921
Number of Samples:12 / 6

Experimental	endometriosis study 6 (minimal/mild endo.; pro. MCP)
	Endometrial tissue samples from women with minimal or mild endometriosis and pelvic pain and/or infertility collected in the proliferative menstrual cycle phase (MCP). Endometriosis was diagnosed based on the revised American Fertility Society classification system. The MCP was determined by endometrial histology, confirmed by estradiol and progesterone serum levels and corroborated by 2 independent bioinformatics methods: clustering in unsupervised whole-transcriptome principal component analysis and cycle phase assignment classifier analysis. Patients with hormonal treatment within previous 3 months and presence of malignancy or major systemic disease were excluded.
Control	endometriosis study 6 (minimal/mild endo.; early se MCP)
	Endometrial tissue samples from women with minimal or mild endometriosis and pelvic pain and/or infertility collected in the early secretory menstrual cycle phase (MCP). Endometriosis was diagnosed based on the revised American Fertility Society classification system. The MCP was determined by endometrial histology, confirmed by estradiol and progesterone serum levels and corroborated by 2 independent bioinformatics methods: clustering in unsupervised whole-transcriptome principal component analysis and cycle phase assignment classifier analysis. Patients with hormonal treatment within previous 3 months and presence of malignancy or major systemic disease were excluded.